Literature DB >> 16540915

West Nile virus induced vocal fold paralysis.

Natalie P Steele1, David Myssiorek.   

Abstract

OBJECTIVE: West Nile virus has recently become a public health concern in the United States, after an outbreak in New York City in 1999. It is a mosquito-borne virus that causes a spectrum of disease from flu-like symptoms to encephalopathy, muscle weakness, and, in some cases, death. STUDY
DESIGN: Case Report.
METHODS: A patient infected with West Nile virus presented with progressive muscle weakness, and later developed bilateral vocal fold paresis. His clinical presentation, physical and laboratory examination findings, and course of illness will be discussed.
RESULTS: After a prolonged hospital stay, and presumptive treatment for Guillain-Barré, repeat CSF analysis revealed infection with the West Nile virus. The patient developed bilateral vocal fold paralysis during his hospital course. At long-term follow-up, the patient's left vocal fold paralysis persisted, while the right vocal fold paralysis had resolved.
CONCLUSIONS: Although several viruses have been associated with recurrent laryngeal nerve injury, this is the first report of West Nile virus induced vocal fold paralysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540915     DOI: 10.1097/01.mlg.0000194637.83266.a3

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

1.  Aortic arch compliance and idiopathic unilateral vocal fold paralysis.

Authors:  Reza Behkam; Kara E Roberts; Andrew J Bierhals; M Eileen Jacobs; Julia D Edgar; Randal C Paniello; Gayle Woodson; Jonathan P Vande Geest; Julie M Barkmeier-Kraemer
Journal:  J Appl Physiol (1985)       Date:  2017-05-18

2.  Unilateral Vocal Cord Paralysis of a Great Jewish Opera Singer.

Authors:  Irit Duek; Jacob T Cohen; Ziv Gil
Journal:  Rambam Maimonides Med J       Date:  2018-01-29

3.  Vocal Fold Paralysis Following COVID-19 Vaccination: Query of VAERS Database.

Authors:  Osama A Hamdi; Rachel H Jonas; James J Daniero
Journal:  J Voice       Date:  2022-01-24       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.